Literature DB >> 20011618

PET imaging for Treatment Response in Cancer.

Janet F Eary.   

Abstract

Entities:  

Year:  2008        PMID： 20011618      PMCID： PMC2790286          DOI： 10.1016/j.cpet.2008.10.001

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


× No keyword cloud information.
  51 in total

1.  PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Authors:  Lale Kostakoglu; Morton Coleman; John P Leonard; Ichiei Kuji; Holly Zoe; Stanley J Goldsmith
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

2.  Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

Authors:  W A Weber; K Ott; K Becker; H J Dittler; H Helmberger; N E Avril; G Meisetschläger; R Busch; J R Siewert; M Schwaiger; U Fink
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

Review 3.  Evaluation of therapy for lymphoma.

Authors:  Guy Jerusalem; Roland Hustinx; Yves Beguin; Georges Fillet
Journal:  Semin Nucl Med       Date:  2005-07       Impact factor: 4.446

4.  Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Authors:  Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix M Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

5.  Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.

Authors:  Hinrich A Wieder; Ambros J Beer; Florian Lordick; Katja Ott; Michael Fischer; Ernst J Rummeny; Sibylle Ziegler; Jörg R Siewer; Markus Schwaiger; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

6.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

7.  18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.

Authors:  Rakesh Kumar; Yan Xiu; Scott Potenta; Ayse Mavi; Hongming Zhuang; Jian Q Yu; Thiruvekatasamy Dhurairaj; Simin Dadparvar; Abass Alavi
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

8.  Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.

Authors:  Scott M Schuetze; Brian P Rubin; Cheryl Vernon; Douglas S Hawkins; James D Bruckner; Ernest U Conrad; Janet F Eary
Journal:  Cancer       Date:  2005-01-15       Impact factor: 6.860

9.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Authors:  R L Wahl; K Zasadny; M Helvie; G D Hutchins; B Weber; R Cody
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

10.  A statistical simulation study finds discordance between WHO criteria and RECIST guideline.

Authors:  Madhu Mazumdar; Alex Smith; Lawrence H Schwartz
Journal:  J Clin Epidemiol       Date:  2004-04       Impact factor: 6.437
View more
  2 in total

1.  The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.

Authors:  Lucia Leccisotti; Maria Antonietta Gambacorta; Chiara de Waure; Antonella Stefanelli; Brunella Barbaro; Fabio Maria Vecchio; Claudio Coco; Roberto Persiani; Antonio Crucitti; Antonino Pio Tortorelli; Alessandro Giordano; Vincenzo Valentini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-17       Impact factor: 9.236

2.  Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Kevin P Horn; Hannah M T Thomas; Hubert J Vesselle; Paul E Kinahan; Robert S Miyaoka; Ramesh Rengan; Jing Zeng; Stephen R Bowen
Journal:  Clin Nucl Med       Date:  2021-11-01       Impact factor: 10.782
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.